During the last session, Baird Medical Investment Holdings Limited (NASDAQ:BDMD)’s traded shares were 36347.0, with the beta value of the company hitting -0.88. At the end of the trading day, the stock’s price was $6.45, reflecting an intraday loss of -9.15% or -$0.65. The 52-week high for the BDMD share is $13.52, that puts it down -109.61 from that peak though still a striking 83.72% gain since the share price plummeted to a 52-week low of $1.05. The company’s market capitalization is $230.45M, and the average intraday trading volume over the past 10 days was 0.12 million shares, and the average trade volume was 49.12K shares over the past three months.

Baird Medical Investment Holdings Limited (NASDAQ:BDMD) trade information

Baird Medical Investment Holdings Limited (BDMD) registered a -9.15% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -9.15% in intraday trading to $6.45, hitting a weekly high. The stock’s 5-day price performance is 48.28%, and it has moved by 25.98% in 30 days. Based on these gigs, the overall price performance for the year is -40.61%. The short interest in Baird Medical Investment Holdings Limited (NASDAQ:BDMD) is 37754.0 shares and it means that shorts have 1.2 day(s) to cover.

BDMD Dividends

Baird Medical Investment Holdings Limited is due to release its next quarterly earnings in July. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Baird Medical Investment Holdings Limited (NASDAQ:BDMD)’s Major holders

Baird Medical Investment Holdings Limited insiders own 99.92% of total outstanding shares while institutional holders control 1.40%, with the float percentage being 1668.36%.